Mesalamine

Alembic Pharmaceuticals received FDA approval of its abbreviated new drug application for mesalamine extended-release capsules indicated for maintenance of remission in ulcerative colitis, according to a manufacturer release.

Sun Pharmaceutical Industries received FDA approval of its abbreviated new drug application for mesalamine extended-release capsules indicated for use in ulcerative colitis, according to a press release.

NAPLES, Florida — Jennifer L. Seminerio, MD, spoke with Healio about key takeaways from her 2022 ACG/FGS Spring Symposium presentation, which focused on treatment for mild to moderate ulcerative colitis and Crohn’s disease.

Mesalamine correlated with the longest life expectancy among older adult patients with inflammatory bowel disease, according to research published in BMC Gastroenterology.

How common is asymptomatic bowel involvement in patients with peripheral or axial SpA? Can we use NSAIDs in these patients? What’s the difference between sulfasalazine and mesalamine? Hear what a rheumatologist should know about IBD!

AUSTIN, Texas — In this exclusive video from Crohn’s & Colitis Congress, James Lindsay, PhD, FRCP, professor of inflammatory bowel disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a consultant gastroenterologist at Barts Health NHS Trust, discusses positioning therapies in ulcerative colitis.

Healio Gastroenterology and Liver Disease presents a list of some of the top stories that included some of the top research and discussions pertaining to inflammatory bowel disease presented at the American College of Gastroenterology Annual Meeting

News about the FDA’s public comment session to hear testimony about their policy on fecal microbiota transplantation for patients with recurrent Clostridioides difficile infection was among the week’s top stories in gastroenterology.

SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than twice as likely to receive mesalamine compared with younger patients, according to data presented at the American College of Gastroenterology Annual Meeting.